Glucagon-like peptide-1 receptor agonists (GLP-1RA) a class of drugs prescribed to treat type 2 diabetes and obesity have seen a surge of popularity in recent years
What this means in practice: Your $50 copay doesn't count toward your Part D deductible It doesn't count toward your $2,100 yearly drug spending cap Extra Help (low-income subsidy) doesn't reduce your copay Your Part D plan sponsor isn't involved CMS manages everything centrally through a designated claims processor However: If your doctor prescribes a GLP-1 for diabetes, sleep apnea, or liver disease, you'll get it through your regular Part D plan, and standard Part D cost-sharing will apply
Insurance companies typically have specific requirements for Ozempic coverage, particularly when it is used for type 2 diabetes, which is its FDA-approved use
The typical dose of 5mg of glycine per mL in the Strive formulation provides a consistent daily dose with each weekly injection
Zlotnik, A., & Yoshie, O
Some strategies, such as requiring participation in lifestyle management programs, limiting coverage to higher-risk populations or applying BMI-based criteria, can reduce rebate value